GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

OPKO Health, Inc. (NASDAQ: OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the company, in partnership with Entera Bio Ltd., announced that new data for ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Two new injectable drugs offer hope to the obese, especially diabetics, and could set off a pharma race to cash in on the ...

A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional ...